Tandem-multimeric F3-gelonin fusion toxins for enhanced anti-cancer activity for prostate cancer treatment
Meong Cheol ShinDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan,428 Church St., Ann Arbor, MI 48109, USAKyoung Ah MinTianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan,428 Church St., Ann Arbor, MI 48109, USA; College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Injero, Gimhae, Gyeongnam, 621-749, Republic of KoreaHeesun CheongComparative Biomedicine Research Branch, Division of Cancer Biology, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi-do, 10408, Republic of KoreaCheol MoonCollege of Pharmacy, Sunchon National University, 255 Jungang-ro, Suncheon, Jeonnam 57922, Republic of KoreaYongzhuo HuangChinese Academy of SciencesHuining HeTianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin 300070, ChinaVictor C. YangTianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan,428 Church St., Ann Arbor, MI 48109, USA. Electronic address: [email protected]
2017en
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba